{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:13:18Z","timestamp":1783426398702,"version":"3.54.6"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejmech.2022.115010","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T01:53:07Z","timestamp":1670637187000},"page":"115010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents"],"prefix":"10.1016","volume":"246","author":[{"given":"Mohd Kamil","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaista","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andleeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif Jamal","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaaz","family":"Khatoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-5672","authenticated-orcid":false,"given":"Sadaf","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejmech.2022.115010_bib1","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019570","article-title":"Black molds and melanized yeasts pathogenic to humans","volume":"5","author":"Chowdhary","year":"2015","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005491","article-title":"Filamentous fungi in respiratory infections. What lies beyond Aspergillosis and Mucormycosis?","volume":"12","author":"Chowdhary","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2022.115010_bib3","series-title":"Complications Coronavirus Can Cause","year":"2021"},{"key":"10.1016\/j.ejmech.2022.115010_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198005","article-title":"Co-infection with respiratory pathogens among COVID-2019 cases","volume":"285","author":"Zhu","year":"2020","journal-title":"Virus Res."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijmmb.2020.10.014","article-title":"Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: implication on antimicrobial resistance","volume":"39","author":"Khurana","year":"2021","journal-title":"Indian J. Med. Microbiol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update","volume":"6","author":"Skiada","year":"2020","journal-title":"J. Fungi"},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/mmy\/myx029","article-title":"Epidemiology and clinical characteristics of invasive mould infections: a multicenter, retrospective analysis in five Asian countries","volume":"56","author":"Rotjanapan","year":"2018","journal-title":"Med. Mycol."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115010_bib8","first-page":"561","article-title":"Overview of treatment options for invasive fungal infections","volume":"49","author":"Pound","year":"2011","journal-title":"Med. Mycol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2020.101007","article-title":"Mucormycosis treatment: recommendations, latest advances, and perspectives","volume":"30","author":"Brunet","year":"2020","journal-title":"J. Mycolog. Med."},{"key":"10.1016\/j.ejmech.2022.115010_bib10","first-page":"135","article-title":"Virulence of Rhizopus species compared with two alternative model systems","author":"Dolatabadi","year":"2015","journal-title":"Mucorales Between Food Infect."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/CMR.12.3.454","article-title":"Developments in fungal taxonomy","volume":"12","author":"Guarro","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2022.115010_bib12","series-title":"Explained: Mucormycosis Aka Black Fungus in Covid-19 Patients; Symptoms, Treatment and How to Prevent it","author":"India","year":"2021"},{"issue":"165","key":"10.1016\/j.ejmech.2022.115010_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115010_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/13693780600928503","article-title":"The weapon potential of human pathogenic fungi","volume":"44","author":"Casadevall","year":"2006","journal-title":"Med. Mycol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib15","doi-asserted-by":"crossref","DOI":"10.18388\/abp.2009_2452","article-title":"Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus","volume":"56","author":"Karkowska-Kuleta","year":"2009","journal-title":"Acta Biochim. Pol."},{"issue":"16","key":"10.1016\/j.ejmech.2022.115010_bib16","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jmb.2019.05.003","article-title":"How environmental fungi cause a range of clinical outcomes in susceptible hosts","volume":"431","author":"Denham","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-021-01504-8","article-title":"Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature","volume":"21","author":"He","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.ejmech.2022.115010_bib18","article-title":"Invasive fungal disease complicating coronavirus disease 2019: when it Rains, it Spores","author":"Hoenigl","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.ejmech.2022.115010_bib19","article-title":"Does pulmonary aspergillosis complicate coronavirus disease 2019?","volume":"2","author":"Beer","year":"2020","journal-title":"Crit. Care Explor."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115010_bib20","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1016\/S2666-5247(21)00148-8","article-title":"Mucormycosis: time to address this deadly fungal infection","volume":"2","author":"Stone","year":"2021","journal-title":"Lancet Microb."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.medcli.2020.08.003","article-title":"Association between high-dose steroid therapy, respiratory function, and time to discharge in patients with COVID-19: cohort study","volume":"156","author":"Rodr\u00edguez-Molinero","year":"2021","journal-title":"Med. Cl\u00ednica"},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11046-020-00472-7","article-title":"Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran","volume":"185","author":"Salehi","year":"2020","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ejmech.2022.115010_bib23","series-title":"Invasive Fungal Disease in Humans: Are We Aware of the Real Impact?","first-page":"115","author":"Firacative","year":"2020"},{"key":"10.1016\/j.ejmech.2022.115010_bib24","doi-asserted-by":"crossref","first-page":"264. e5","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ejmech.2022.115010_bib25","series-title":"Fungus in a Viral Land-Orbital Mucormycosis in Patients with COVID-19 Infection","author":"Imam","year":"2021"},{"key":"10.1016\/j.ejmech.2022.115010_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2021.105957","article-title":"Sino-orbital mucormycosis in a COVID-19 patient: a case report","volume":"82","author":"Maini","year":"2021","journal-title":"Int. J. Surg. Case Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/diseases9040065","article-title":"COVID-19 associated mucormycosis: a systematic review from diagnostic challenges to management","volume":"9","author":"Yasmin","year":"2021","journal-title":"Diseases"},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib28","first-page":"253","article-title":"Clinical profile of mucormycosis: a study from teaching hospital in North Karnataka, India","volume":"3","author":"Rajoor","year":"2016","journal-title":"Int. J. Intg. Med. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.18203\/issn.2454-5929.ijohns20211583","article-title":"A case series of invasive mucormycosis in patients with COVID-19 infection","volume":"7","author":"Mishra","year":"2021","journal-title":"Int. J. Otorhinolaryngol. Head Neck Surg."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib30","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J. Laryngol. Otol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis","volume":"49","author":"Pasero","year":"2021","journal-title":"Infection"},{"issue":"6","key":"10.1016\/j.ejmech.2022.115010_bib32","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: a case report","volume":"53","author":"do Monte Junior","year":"2020","journal-title":"Clin. Endosc."},{"key":"10.1016\/j.ejmech.2022.115010_bib33","article-title":"Title of the Article: Paranasal Mucormycosis in COVID-19 Patient","author":"Saldanha","year":"2021","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115010_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","article-title":"Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review","volume":"6","author":"Tamez-P\u00e9rez","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejmech.2022.115010_bib35","author":"India"},{"key":"10.1016\/j.ejmech.2022.115010_bib36","author":"News"},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib37","first-page":"418","article-title":"The rising Havoc of the black, white and Yellow fungi in India","volume":"3","author":"Mishra","year":"2021","journal-title":"Biotica Res. Today"},{"issue":"suppl_1","key":"10.1016\/j.ejmech.2022.115010_bib38","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"Alekseyev","year":"2021","journal-title":"J. Med. Cases"},{"issue":"10","key":"10.1016\/j.ejmech.2022.115010_bib40","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14737159.2018.1522250","article-title":"Recent advances in the molecular diagnosis of mucormycosis","volume":"18","author":"Dadwal","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"9","key":"10.1016\/j.ejmech.2022.115010_bib41","doi-asserted-by":"crossref","first-page":"810. e1","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"issue":"suppl_1","key":"10.1016\/j.ejmech.2022.115010_bib42","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what, and how?","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"10\u201311","key":"10.1016\/j.ejmech.2022.115010_bib43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00249-014-0983-8","article-title":"Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments","volume":"43","author":"Kami\u0144ski","year":"2014","journal-title":"Eur. Biophys. J."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/1389557516666160118112103","article-title":"The mechanistic targets of antifungal agents: an overview","volume":"16","author":"K Mazu","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof7010001","article-title":"Sterol 14\u03b1-demethylase ligand-binding pocket-mediated acquired and intrinsic azole resistance in fungal pathogens","volume":"7","author":"Rosam","year":"2021","journal-title":"J. Fungi"},{"issue":"10","key":"10.1016\/j.ejmech.2022.115010_bib47","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1345\/aph.1M237","article-title":"Echinocandins: the newest class of antifungals","volume":"43","author":"Sucher","year":"2009","journal-title":"Ann. Pharmacother."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115010_bib48","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1, 3-beta-D-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ejmech.2022.115010_bib49","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","author":"Warrilow","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib50","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.1093\/cid\/ciaa1204","article-title":"A randomized phase 2 study of VT-1161 for the treatment of acute vulvovaginal Candidiasis","volume":"73","author":"Brand","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.115010_bib51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.1992.tb00001.x","article-title":"Terbinafine: mode of action and properties of the squalene epoxidase inhibition","volume":"126","author":"Ryder","year":"1992","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/EC.05284-11","article-title":"Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor","volume":"11","author":"Bastidas","year":"2012","journal-title":"Eukaryot. Cell"},{"issue":"16","key":"10.1016\/j.ejmech.2022.115010_bib53","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","article-title":"Cyclophilin D as a drug target","volume":"10","author":"Waldmeier","year":"2003","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2022.115010_bib54","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib55","first-page":"1","article-title":"Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14\/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.115010_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107483","article-title":"Antifungal effects of statins","volume":"208","author":"Tavakkoli","year":"2020","journal-title":"Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115010_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw1327","article-title":"Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis","volume":"5","author":"Gebremariam","year":"2019","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib58","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.ejmech.2022.115010_bib59","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.1015023108","article-title":"Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities","volume":"108","author":"Palacios","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2022.115010_bib60","first-page":"241","article-title":"Clinical Mycology","author":"Ibrahim","year":"2003","journal-title":"Zygomycosis"},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/ajcp\/64.4.544","article-title":"Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia","volume":"64","author":"Kwan-Chung","year":"1975","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ejmech.2022.115010_bib62","first-page":"2973","article-title":"Agents of mucormycosis and related species","volume":"2","author":"Sugar","year":"2005","journal-title":"Princ. Pract. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib63","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-012-0272-6","article-title":"Rhino-orbital-cerebral mucormycosis","volume":"14","author":"Gamaletsou","year":"2012","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115010_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00653-19","article-title":"A revised species concept for opportunistic Mucor species reveals species-specific antifungal susceptibility profiles","volume":"63","author":"Wagner","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000549","article-title":"Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication","volume":"5","author":"Ma","year":"2009","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib67","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13693780310001644644","article-title":"Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient","volume":"42","author":"Quinio","year":"2004","journal-title":"Med. Mycol."},{"issue":"3\u20134","key":"10.1016\/j.ejmech.2022.115010_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1439-0507.2004.00959.x","article-title":"Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis","volume":"47","author":"Eisen","year":"2004","journal-title":"Mycoses"},{"issue":"11","key":"10.1016\/j.ejmech.2022.115010_bib70","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1128\/AAC.47.11.3647-3650.2003","article-title":"Activity of posaconazole in treatment of experimental disseminated zygomycosis","volume":"47","author":"Dannaoui","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000238681","article-title":"Treatment of experimental zygomycosis in Guinea pigs with azoles and with amphotericin B","volume":"35","author":"Van Cutsem","year":"1989","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib73","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.46.4.1032-1037.2002","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib74","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/AAC.46.7.2310-2312.2002","article-title":"In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115010_bib75","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/375075","article-title":"Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy","volume":"36","author":"Tob\u00f3n","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.ejmech.2022.115010_bib76","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1469-0691.2004.00945.x","article-title":"Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?","volume":"10","author":"Ide","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115010_bib77","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/AAC.00004-15","article-title":"Etest cannot be recommended for in vitro susceptibility testing of Mucorales","volume":"59","author":"Caramalho","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115010_bib78","doi-asserted-by":"crossref","first-page":"6767","DOI":"10.1128\/AAC.03569-14","article-title":"Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis","volume":"58","author":"Lewis","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ejmech.2022.115010_bib79","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1128\/AAC.01583-15","article-title":"Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae","volume":"59","author":"Bellanger","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib80","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/01.tp.0000168343.47569.1c","article-title":"Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy","volume":"80","author":"Dupont","year":"2005","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/jof4030090","article-title":"Therapy of mucormycosis","volume":"4","author":"Sipsas","year":"2018","journal-title":"J. Fungi"},{"issue":"12","key":"10.1016\/j.ejmech.2022.115010_bib82","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1128\/AAC.01919-15","article-title":"In vitro activity of isavuconazole and comparators against clinical isolates of the Mucorales order","volume":"59","author":"Arendrup","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115010_bib83","first-page":"79","article-title":"Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections","volume":"9","author":"Donnelley","year":"2016","journal-title":"Infect. Drug Resist."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib84","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1128\/AAC.02301-13","article-title":"Isavuconazole therapy protects immunosuppressed mice from mucormycosis","volume":"58","author":"Luo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib85","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/JCM.03176-13","article-title":"Isavuconazole treatment of a patient with disseminated mucormycosis","volume":"52","author":"Peixoto","year":"2014","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib86","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s15010-013-0552-6","article-title":"Successful isavuconazole salvage therapy in a patient with invasive mucormycosis","volume":"42","author":"Ervens","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.ejmech.2022.115010_bib87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mmcr.2016.03.002","article-title":"Isavuconazole as salvage therapy for mucormycosis","volume":"11","author":"Graves","year":"2016","journal-title":"Med. Mycol. Case Rep."},{"issue":"19","key":"10.1016\/j.ejmech.2022.115010_bib88","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1021\/acs.jmedchem.0c00345","article-title":"Synthetic approaches to new drugs approved during 2018","volume":"63","author":"Flick","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/02681219780000961","article-title":"Lipopeptide inhibitors of fungal glucan synthase","volume":"35","author":"Kurtz","year":"1997","journal-title":"J. Med. Vet. Mycol."},{"issue":"10","key":"10.1016\/j.ejmech.2022.115010_bib90","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.ejmech.2022.115010_bib91","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/AAC.41.8.1835","article-title":"In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds","volume":"41","author":"Del Poeta","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib92","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib93","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ejmech.2022.115010_bib94","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1128\/AAC.01437-15","article-title":"VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection","volume":"59","author":"Gebremariam","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib95","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2022.115010_bib96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/myc.12234","article-title":"Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India","volume":"57","author":"Chowdhary","year":"2014","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib97","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/AAC.01812-10","article-title":"Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis","volume":"55","author":"Lewis","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib98","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1128\/AAC.02612-12","article-title":"Drug combinations against Mucor irregularis in vitro","volume":"57","author":"Zhang","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2022.115010_bib99","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/AAC.00234-15","article-title":"Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates","volume":"59","author":"Lamoth","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01941-17","article-title":"In vitro and in vivo efficacy of a novel and long-acting fungicidal azole, PC1244, on Aspergillus fumigatus infection","volume":"62","author":"Colley","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib101","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.00956-09","article-title":"Antifungal activity of colistin against Mucorales species in vitro and in a murine model of Rhizopus oryzae pulmonary infection","volume":"54","author":"Ben-Ami","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115010_bib102","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2217\/fvl-2019-0076","article-title":"The antiviral Sofosbuvir against mucormycosis: an in silico perspective","volume":"14","author":"Elfiky","year":"2019","journal-title":"Future Virol."},{"issue":"212","key":"10.1016\/j.ejmech.2022.115010_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2122003re15","article-title":"TOR signaling","volume":"2003","author":"Harris","year":"2003","journal-title":"Sci. STKE"},{"key":"10.1016\/j.ejmech.2022.115010_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112082","article-title":"New azole antifungals with a fused triazinone scaffold","volume":"189","author":"Montoir","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib105","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1365-2958.2003.03481.x","article-title":"Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly","volume":"48","author":"Tsukahara","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2022.115010_bib106","series-title":"Abstr Intersci Conf Antimicrob Agents Chemother, Poster F1-1377","article-title":"In vitro and in vivo antifungal activities of E1211, a water-soluble prodrug of E1210","author":"Hata","year":"2011"},{"issue":"10","key":"10.1016\/j.ejmech.2022.115010_bib107","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1128\/AAC.00366-11","article-title":"Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis","volume":"55","author":"Hata","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib108","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01387-19","article-title":"Evaluation of resistance development to the Gwt1 inhibitor manogepix (APX001A) in Candida species","volume":"64","author":"Kapoor","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ejmech.2022.115010_bib109","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jac\/dkz022","article-title":"In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies","volume":"74","author":"Rivero-Menendez","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1128\/AAC.05414-11","article-title":"Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods","volume":"56","author":"Castanheira","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.ejmech.2022.115010_bib111","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1128\/AAC.00570-11","article-title":"In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods","volume":"55","author":"Pfaller","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ejmech.2022.115010_bib112","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00178-20","article-title":"Fosmanogepix (APX001) is effective in the treatment of pulmonary murine mucormycosis due to Rhizopus arrhizus","volume":"64","author":"Gebremariam","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.115010_bib113","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molstruc.2017.09.086","article-title":"New spiro-oxindole constructed with pyrrolidine\/thioxothiazolidin-4-one derivatives: regioselective synthesis, x-ray crystal structures, Hirshfeld surface analysis, DFT, docking and antimicrobial studies","volume":"1152","author":"Barakat","year":"2018","journal-title":"J. Mol. Struct."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/molecules22030357","article-title":"Facial regioselective synthesis of novel bioactive spiropyrrolidine\/pyrrolizine-oxindole derivatives via a three components reaction as potential antimicrobial agents","volume":"22","author":"Hassaneen","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib115","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01291-18","article-title":"Overexpression or deletion of ergosterol biosynthesis genes alters doubling time, response to stress agents, and drug susceptibility in Saccharomyces cerevisiae","volume":"9","author":"Bhattacharya","year":"2018","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.ejmech.2022.115010_bib116","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1042\/BST0351529","article-title":"Biological consequences of statins in Candida species and possible implications for human health","volume":"35","author":"Wikhe","year":"2007","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib117","first-page":"3","article-title":"Lovastatin effect on ergosterol production and growth of Tolypocladium inflatum 106","volume":"49","author":"Bibikova","year":"2004","journal-title":"Antibiotiki i khimioterapiia= Antibiotics and chemoterapy [sic]"},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib118","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1567-1364.2009.00593.x","article-title":"Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation","volume":"10","author":"Callegari","year":"2010","journal-title":"FEMS Yeast Res."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib119","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1099\/jmm.0.013946-0","article-title":"In vitro interactions between primycin and different statins in their effects against some clinically important fungi","volume":"59","author":"Nyilasi","year":"2010","journal-title":"J. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.115010_bib120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","article-title":"In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi","volume":"307","author":"Nyilasi","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib121","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1556\/ABiol.61.2010.3.11","article-title":"Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes","volume":"61","author":"Galg\u00f3czy","year":"2010","journal-title":"Acta Biol. Hung."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib122","first-page":"33","article-title":"Effect of different statins on the antifungal activity of polyene antimycotics","volume":"54","author":"Nyilasi","year":"2010","journal-title":"Acta Biol. Szeged."},{"issue":"3","key":"10.1016\/j.ejmech.2022.115010_bib123","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1086\/600825","article-title":"Are statins applicable for the prevention and treatment of zygomycosis?","volume":"49","author":"Galg\u00f3czy","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib124","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","article-title":"Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole","volume":"50","author":"Chamilos","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiw090","article-title":"Statin concentrations below the minimum inhibitory concentration attenuate the virulence of Rhizopus oryzae","volume":"214","author":"Bellanger","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1574-6968.2007.00661.x","article-title":"Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive Zygomycetes","volume":"270","author":"Galg\u00f3czy","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2022.115010_bib127","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.fgb.2019.04.008","article-title":"CRISPR-Cas9-mediated disruption of the HMG-CoA reductase genes of Mucor circinelloides and subcellular localization of the encoded enzymes","volume":"129","author":"Nagy","year":"2019","journal-title":"Fungal Genet. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.115010_bib128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10482-008-9287-2","article-title":"Cloning of the Rhizomucor miehei 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene and its heterologous expression in Mucor circinelloides","volume":"95","author":"Luk\u00e1cs","year":"2009","journal-title":"Antonie Leeuwenhoek"},{"issue":"4","key":"10.1016\/j.ejmech.2022.115010_bib129","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jiph.2022.02.007","article-title":"Mucormycosis and COVID-19 pandemic: clinical and diagnostic approach","volume":"15","author":"Azhar","year":"2022","journal-title":"J. Infect. Public Health"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422009126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:51:35Z","timestamp":1759330295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422009126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":129,"alternative-id":["S0223523422009126"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115010","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.115010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115010"}}